ZNF703 and breast carcinoma: MCF7-ZNF703/GFP was chosen because it is a luminal breast cancer cell line in which ZNF703 was artificially overexpressed leading to various consequences including cell proliferation and resistance to tamoxifen previously reported and known to reflect luminal B phenotype [34].